U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.2926_2927delinsAT (p.Ser976Ile) AND Breast-ovarian cancer, familial, susceptibility to, 2

Germline classification:
Likely benign (3 submissions)
Last evaluated:
Dec 22, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000113115.13

Allele description [Variation Report for NM_000059.4(BRCA2):c.2926_2927delinsAT (p.Ser976Ile)]

NM_000059.4(BRCA2):c.2926_2927delinsAT (p.Ser976Ile)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.2926_2927delinsAT (p.Ser976Ile)
Other names:
p.S976I:TCC>ATC
HGVS:
  • NC_000013.11:g.32337281_32337282delinsAT
  • NG_012772.3:g.26802_26803delinsAT
  • NM_000059.4:c.2926_2927delinsATMANE SELECT
  • NP_000050.3:p.Ser976Ile
  • LRG_293:g.26802_26803delinsAT
  • NC_000013.10:g.32911418_32911419delinsAT
  • NM_000059.3:c.2926_2927delTCinsAT
  • NM_000059.4:c.2926_2927delinsAT
  • U43746.1:n.3154_3155delTCinsAT
  • p.S976I
Protein change:
S976I
Links:
dbSNP: rs276174831
NCBI 1000 Genomes Browser:
rs276174831
Molecular consequence:
  • NM_000059.4:c.2926_2927delinsAT - missense variant - [Sequence Ontology: SO:0001583]
Observations:
26

Condition(s)

Name:
Breast-ovarian cancer, familial, susceptibility to, 2 (BROVCA2)
Synonyms:
Breast-ovarian cancer, familial 2
Identifiers:
MONDO: MONDO:0012933; MedGen: C2675520; Orphanet: 145; OMIM: 612555

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000146141Breast Cancer Information Core (BIC) (BRCA2)
no assertion criteria provided
Benign
(May 29, 2002)
germlineclinical testing

SCV000488048Counsyl
criteria provided, single submitter

(Counsyl Autosomal Dominant Disease Classification criteria (2015))
Likely benign
(Dec 22, 2015)
unknownclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Counsyl Autosomal Dominant Disease Classification criteria (2015),

Citation Link,

SCV004228391Department of Medical and Surgical Sciences, University of Bologna
no assertion criteria provided
Likely benign
(Sep 1, 2023)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes11not providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
Africangermlineyes9not providednot providednot providednot providedclinical testing
African, African Americangermlineyes1not providednot providednot providednot providedclinical testing
African, Latin American, Caribbean, Bahamiangermlineyes1not providednot providednot providednot providedclinical testing
Asian, Trinidadian Western Indiesgermlineyes1not providednot providednot providednot providedclinical testing
Latin American, Caribbeangermlineyes2not providednot providednot providednot providedclinical testing
Western European, Latin American, Caribbegermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.

Bodian DL, McCutcheon JN, Kothiyal P, Huddleston KC, Iyer RK, Vockley JG, Niederhuber JE.

PLoS One. 2014;9(4):e94554. doi: 10.1371/journal.pone.0094554.

PubMed [citation]
PMID:
24728327
PMCID:
PMC3984285

Breast cancer genetics in African Americans.

Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C.

Cancer. 2003 Jan 1;97(1 Suppl):236-45. Review.

PubMed [citation]
PMID:
12491487
See all PubMed Citations (5)

Details of each submission

From Breast Cancer Information Core (BIC) (BRCA2), SCV000146141.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided7not providednot providedclinical testingnot provided
2not provided1not providednot providedclinical testingnot provided
3not provided3not providednot providedclinical testingnot provided
4African9not providednot providedclinical testingnot provided
5African, African American1not providednot providedclinical testingnot provided
6African, Latin American, Caribbean, Bahamian1not providednot providedclinical testingnot provided
7Asian, Trinidadian Western Indies1not providednot providedclinical testingnot provided
8Latin American, Caribbean2not providednot providedclinical testingnot provided
9Western European, Latin American, Caribbe1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided7not providednot providednot provided
2germlineyesnot providednot providednot provided1not providednot providednot provided
3germlineyesnot providednot providednot provided3not providednot providednot provided
4germlineyesnot providednot providednot provided9not providednot providednot provided
5germlineyesnot providednot providednot provided1not providednot providednot provided
6germlineyesnot providednot providednot provided1not providednot providednot provided
7germlineyesnot providednot providednot provided1not providednot providednot provided
8germlineyesnot providednot providednot provided2not providednot providednot provided
9germlineyesnot providednot providednot provided1not providednot providednot provided

From Counsyl, SCV000488048.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Department of Medical and Surgical Sciences, University of Bologna, SCV004228391.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

BP1(Strong) according to ACMG/AMP classification guidelines specified for BRCA1 & BRCA2 (Classification Criteria V1.0.0 2023-09-08 - https://cspec.genome.network/cspec/ui/svi/affiliation/50087) (PMID: 38160042)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024